Adipose stromal vascular fraction improves cardiac function in chronic myocardial infarction through differentiation

Manuel Mazo1, Arantxa Cemborain, Juan José Gavira

  • 1Hematology and Cell Therapy and Foundation for Applied Medical Research, Division of Cancer, Clínica Universitaria, University of Navarra, Navarra, Spain.

Cell Transplantation
|February 7, 2012
PubMed

Insights

Adipose-derived stromal vascular fraction (SVF) cells significantly improve heart function and tissue metabolism for 3 months in a chronic myocardial infarction (MI) rat model. These cells promote cardiac regeneration and long-term benefits through direct and indirect mechanisms.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Cell Therapy

Background:

  • Acute myocardial infarction (MI) treatment with adipose-derived cells is established, but chronic effects remain unclear.
  • Investigating long-term efficacy of stromal vascular fraction (SVF) cell transplantation in chronic MI is crucial.

Purpose of the Study:

  • To evaluate the long-term impact of SVF cell transplantation on cardiac function and metabolism in a rat model of chronic MI.
  • To elucidate the mechanisms underlying SVF cell-mediated cardiac repair.

Main Methods:

  • Chronic MI induced in 82 rats via coronary artery ligation.
  • Intramyocardial injection of 10^7 GFP-expressing SVF cells or control media 5 weeks post-MI.
  • Assessment of cardiac function (echocardiography), metabolism (18F-FDG-microPET), and histology up to 3 months post-transplantation.

Main Results:

  • SVF cell transplantation led to significant, long-lasting (3 months) improvements in cardiac function and metabolism.
  • Histological analysis revealed increased revascularization, positive cardiac remodeling, smaller infarct size, thicker infarct wall, reduced fibrosis, and lower hypertrophy.
  • Engrafted SVF cells were detected for at least 3 months, contributing to vasculature and myofibroblasts, and releasing angiogenic and trophic factors.

Conclusions:

  • SVF cell transplantation offers significant long-term functional benefits in chronic MI.
  • SVF cells promote cardiac tissue regeneration via direct cellular contributions and indirect paracrine effects.
  • SVF cell therapy holds potential for treating chronic ischemic heart disease.

Related Concept Videos